On 26 january, the annual meeting of the academic council and the academic exchange conference for 2025 of the national priority laboratory for drug chemical biology (hereinafter referred to as “the full heavy laboratory”) was held at the joint international biomedicine institute in tianjin (hereinafter referred to as “the joint medicine institute”)。
Academic leadership: insight frontier, solid foundation for innovation
At the opening of the congress, professor condÉ, the director of the full laboratory, reported on the breakthrough in the laboratory's scientific layout and original innovation in 2025. This was followed by an excellent academic report, in which b. A. Luo ei ping described “health science innovation and transformation driven by chinese medicine's wisdom”. It was a group of high-level young people from various countries abroad who demonstrated the latest research and development in their academic fields, highlighting the deep potential of basic research。
Industrial integration: join forces and close the core track
Promoting the efficient transformation of scientific research was a central highlight of the conference. A series of heavy signing and disclosure ceremonies were held. Among them, a strategic cooperation agreement was formally signed between the leading firm in the field of diagnostics, dana tianjin biotech, inc., and tianjin biotech, the leading company in high-end complex agents. The two sides will jointly develop new, improved inhaled powder sprays for the treatment of invasive pulmonary fungi infections, based on patented technology for autonomous intellectual property rights in twilight organisms, with the aim of breaking the long-standing monopoly of multinational pharmaceutical companies in this area and improving clinical access。
A common insight into clinical imperatives has benefited from the long-standing interface between innovative soil and resources provided by the jinxi joint hospital. In addition, the "ai+medical industry alliance of tianjin city" was officially unveiled, and three technology conversion centres, such as ai+ slow disease management, were launched in parallel. The zin pharmaceutical complex has also signed multi-dimensional cooperation agreements with various institutions, such as central koda and china mobile, to further the network of woven industries。
Platform empowerment: a staff visit to witness transformation
In order to further the understanding of the innovative practices across the chain, the meeting was attended by a group of experts who were dedicated to the zin medicine complex and were aware of the substantial progress made by the zin medicine complex in setting up specialized platforms, supporting critical technology clearances and nurturing technology-based enterprises. During the tour, academics were impressed by the excellent hardware facilities, the dynamic climate of innovation and the lively cases of conversion, which fully recognized the key role of the zin pharmaceutical complex as a national platform in linking the “basic research-technology development-industrial transformation” chain。
In its activities, the secretary of the party of the union college of medicines, liu dawg, stated that the united college of medicines had been working to build a collaborative innovation system of “work medicine”. The conference and the signing of the agreement were the central expression of the collaborative initiative of the jinxi joint institute to bring together intellectual resources, link industrial chains and catalyse quality cooperation。
Eco-prosperity: exploiting continued vitality by putting on the list
The conference's parallel forum on the development of innovations in incubating enterprises, which launched the project “closing the show of the good” in its old name, focused on the greater health field, furthered the efficient interface between research needs and market capital. Industrialization experiences have been shared by companies such as ingenious contai, orange family, and live interaction has shown the ecological dynamism of the regional biomedical industry。
Through the powerful drive of the core platform of the zinpharmaceuticals federation, the front-line discovery of the national priority laboratory for pharmacology is accelerating towards addressing clinical difficulties and improving real productivity at the industrial level, injecting a strong “tientific energy” into the high-quality development of biomedicine in our country。
